ProtoKinetix, Incorporated (PKTX)
- Previous Close
0.0186 - Open
0.0186 - Bid --
- Ask --
- Day's Range
0.0150 - 0.0190 - 52 Week Range
0.0101 - 0.0300 - Volume
75,669 - Avg. Volume
97,534 - Market Cap (intraday)
6.588M - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Apr 29, 2024 - May 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
www.protokinetix.comRecent News: PKTX
Performance Overview: PKTX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PKTX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PKTX
Valuation Measures
Market Cap
6.59M
Enterprise Value
6.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
15.11
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-17.88
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-55.05%
Return on Equity (ttm)
-96.94%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-415.48k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
20.41k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-267.4k
Company Insights: PKTX
PKTX does not have Company Insights